Clinigen delivers strong growth boosted by acquisitions
Specialist pharma services company Clinigen (CLIN:AIM) reported full-year gross profits in-line with the July trading statement, up 30% to £182.3m. The market pushed the shares up 1.25% to 894.5p.The company released its first...
19 September 2019